LungQ™ Clinical Suite

Thirona

Thirona’s lung quantification software offers analysis of chest CT scans based on artificial intelligence, aiding in the detection, evaluation, and treatment planning of lung diseases. Analysis provided by the software include quantifications of anatomical volumes, disease distributions, airway morphology, vascular morphology, fissure completeness, and analysis of COVID related abnormalities.

Information source: Vendor
Last updated: June 6, 2024

General Information

General
Product name	LungQ™ Clinical Suite
Company	Thirona
Subspeciality	Chest
Modality	CT
Disease targeted	COPD, emphysema, airtrapping, asthma, cystic fibrosis, COVID-19
Key-features	Volume segmentation and quantification, volume density analysis, airway morphology , vascular morphology, fissure completeness analysis
Suggested use	During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion, treatment planning

Technical Specifications

Data characteristics
Population	All chest CT scans
Input	Volumetric chest CT, 3D, thin slice
Input format	DICOM
Output	Html report, pdf report, JSON file, segmentation overlays, quantitative values
Output format	html, pdf, zraw, JSON
Technology
Integration	Integration via AI marketplace or distribution platform, Stand-alone webbased
Deployment	Locally on dedicated hardware
Trigger for analysis	Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time	> 10 minutes

Regulatory

Certification
CE	Certified, Class IIa , MDR
FDA	510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)

Market

Market presence
On market since	09-2016
Distribution channels	StratX, Blackford
Countries present (clinical, non-research use)	22
Paying clinical customers (institutes)	400
Research/test users (institutes)	10
Pricing
Pricing model	Pay-per-use
Based on	Number of analyses

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers	Five-Year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study. (read) Airway wall thickening on CT: relation to smoking status and severity of COPD (read) Disease Severity Dependence of the Longitudinal Association Between CT Lung Density and Lung Function in Smokers. (read) Predicting Lung Volume Reduction after Endobronchial Valve Therapy Is Maximized Using a Combination of Diagnostic Tools (read)